Julie Panepinto is the Director of the Division of Blood Diseases and Resources (DBDR) at the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Prior to joining the NHLBI in June 2021, as the Deputy Director of DBDR, Dr. Panepinto was a tenured Professor of Pediatrics, Hematology, Vice Chair of Value in Pediatrics, and the Director of the Center for Clinical Effectiveness Research of the Children’s Research Institute at the Medical College of Wisconsin and Children’s Wisconsin. As a clinician researcher with a background in public health, Dr. Panepinto focused her academic career on understanding and improving the health outcomes of patients and families with chronic diseases. Her research focused on integrating the perspective of the patient and family in health care through the use of patient reported outcomes (PROs) and understanding systems of care and acute care utilization for those individuals living with sickle cell disease.
Dr. Panepinto completed her fellowship in Pediatric Hematology/Oncology/Bone Marrow Transplant at the University of Colorado Health Sciences in Denver, Colorado, where she also earned a Master of Science in Public Health. She served as a past member on the NHLBI Data and Safety Monitoring Board (DSMB) for the Sickle Cell Disease Clinical Research Network (2006-2010), the NHLBI’s Sickle Cell Disease Advisory Committee from 2016-2019, and the Advisory Council for the NHLBI from 2020-2021.
Online profile
Original published date
Original source URL
Original source title
oneSCDvoice
Original updated date